Effect Modification by Age on the Benefit or Harm of Antihypertensive Treatment for Elderly Hypertensives: A Systematic Review and Meta-analysis
Abstract
Abstract BACKGROUND The influence of age on balance of benefit vs. potential harm of blood pressure (BP)-lowering therapy for elderly hypertensives is unclear. We evaluated the modifying effects of age on BP lowering for various adverse outcomes in hypertensive patients older than 60 years without specified comorbidities. METHODS All relevant randomized controlled trials (RCTs) were systematically identified. Coronary heart disease, stroke, heart failure (HF), cardiovascular death, major adverse cardiovascular events (MACE), renal failure (RF), and all-cause death were assessed. Meta-regression analysis was used to explore the relationship between achieved systolic BP (SBP) and the risk of adverse events. Random-effects meta-analysis was used to pool the estimates. RESULTS Our study included 18 RCTs (n = 53,993). Meta-regression analysis showed a lower achieved SBP related with a lower risk of stroke and cardiovascular death, but an increased risk of RF. The regression slopes were comparable between populations stratifying by age 75 years. In subgroup analysis, the relative risks of a more aggressive BP lowering strategy were similar between patients aged older or less than 75 years for all outcomes except for RF (P for interaction = 0.02). Compared to treatment with final achieved SBP 140–150 mm Hg, a lower achieved SBP (<140more »
- Authors:
-
- Center for Evidence-based Medicine, Taipei Veterans General Hospital, Taipei, Taiwan
- General Clinical Research Center, Taipei Veterans General Hospital, Taipei, Taiwan
- Institute of Cardiovascular Sciences, University College London (UCL) and National Institute for Health Research (NIHR) UCL Hospitals Biomedical Research Centre, London, UK
- Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan
- Division of Cardiology, Department of Internal Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, Department of Medicine, National Yang-Ming University, Taipei, Taiwan
- Department of Medicine, National Yang-Ming University, Taipei, Taiwan, Division of Faculty Development, Department of Medical Education, Taipei Veterans General Hospital, Taipei, Taiwan, Institute of Public Health and Community Medicine Research Center, National Yang-Ming University, Taipei, Taiwan
- Division of Cardiology, National Taiwan University Hospital, Taipei, Taiwan
- Center for Evidence-based Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, Department of Medicine, National Yang-Ming University, Taipei, Taiwan, Division of Faculty Development, Department of Medical Education, Taipei Veterans General Hospital, Taipei, Taiwan, Institute of Public Health and Community Medicine Research Center, National Yang-Ming University, Taipei, Taiwan
- Publication Date:
- Sponsoring Org.:
- USDOE Office of Electricity (OE), Advanced Grid Research & Development. Power Systems Engineering Research
- OSTI Identifier:
- 1490896
- Alternate Identifier(s):
- OSTI ID: 1485519
- Grant/Contract Number:
- NO1-AG-1-2118
- Resource Type:
- Published Article
- Journal Name:
- American Journal of Hypertension
- Additional Journal Information:
- Journal Name: American Journal of Hypertension Journal Volume: 32 Journal Issue: 2; Journal ID: ISSN 0895-7061
- Publisher:
- Oxford University Press
- Country of Publication:
- United States
- Language:
- English
Citation Formats
Huang, Chi-Jung, Chiang, Chern-En, Williams, Bryan, Kario, Kazuomi, Sung, Shih-Hsien, Chen, Chen-Huan, Wang, Tzung-Dau, and Cheng, Hao-Min. Effect Modification by Age on the Benefit or Harm of Antihypertensive Treatment for Elderly Hypertensives: A Systematic Review and Meta-analysis. United States: N. p., 2018.
Web. doi:10.1093/ajh/hpy169.
Huang, Chi-Jung, Chiang, Chern-En, Williams, Bryan, Kario, Kazuomi, Sung, Shih-Hsien, Chen, Chen-Huan, Wang, Tzung-Dau, & Cheng, Hao-Min. Effect Modification by Age on the Benefit or Harm of Antihypertensive Treatment for Elderly Hypertensives: A Systematic Review and Meta-analysis. United States. https://doi.org/10.1093/ajh/hpy169
Huang, Chi-Jung, Chiang, Chern-En, Williams, Bryan, Kario, Kazuomi, Sung, Shih-Hsien, Chen, Chen-Huan, Wang, Tzung-Dau, and Cheng, Hao-Min. Fri .
"Effect Modification by Age on the Benefit or Harm of Antihypertensive Treatment for Elderly Hypertensives: A Systematic Review and Meta-analysis". United States. https://doi.org/10.1093/ajh/hpy169.
@article{osti_1490896,
title = {Effect Modification by Age on the Benefit or Harm of Antihypertensive Treatment for Elderly Hypertensives: A Systematic Review and Meta-analysis},
author = {Huang, Chi-Jung and Chiang, Chern-En and Williams, Bryan and Kario, Kazuomi and Sung, Shih-Hsien and Chen, Chen-Huan and Wang, Tzung-Dau and Cheng, Hao-Min},
abstractNote = {Abstract BACKGROUND The influence of age on balance of benefit vs. potential harm of blood pressure (BP)-lowering therapy for elderly hypertensives is unclear. We evaluated the modifying effects of age on BP lowering for various adverse outcomes in hypertensive patients older than 60 years without specified comorbidities. METHODS All relevant randomized controlled trials (RCTs) were systematically identified. Coronary heart disease, stroke, heart failure (HF), cardiovascular death, major adverse cardiovascular events (MACE), renal failure (RF), and all-cause death were assessed. Meta-regression analysis was used to explore the relationship between achieved systolic BP (SBP) and the risk of adverse events. Random-effects meta-analysis was used to pool the estimates. RESULTS Our study included 18 RCTs (n = 53,993). Meta-regression analysis showed a lower achieved SBP related with a lower risk of stroke and cardiovascular death, but an increased risk of RF. The regression slopes were comparable between populations stratifying by age 75 years. In subgroup analysis, the relative risks of a more aggressive BP lowering strategy were similar between patients aged older or less than 75 years for all outcomes except for RF (P for interaction = 0.02). Compared to treatment with final achieved SBP 140–150 mm Hg, a lower achieved SBP (<140 mm Hg) was significantly associated with decreased risk of stroke (relative risk = 0.68; 95% confidence interval = 0.55–0.85), HF (0.77; 0.60–0.99), cardiovascular death (0.68; 0.52–0.89), and MACE (0.83; 0.69–0.99). CONCLUSIONS To treat hypertension in the elderly, age had trivial effect modification on most outcomes, except for renal failure. Close monitoring of renal function may be warranted in the management of elderly hypertension.},
doi = {10.1093/ajh/hpy169},
journal = {American Journal of Hypertension},
number = 2,
volume = 32,
place = {United States},
year = {Fri Nov 16 00:00:00 EST 2018},
month = {Fri Nov 16 00:00:00 EST 2018}
}
https://doi.org/10.1093/ajh/hpy169
Web of Science
Works referenced in this record:
Bias in meta-analysis detected by a simple, graphical test
journal, September 1997
- Egger, M.; Smith, G. D.; Schneider, M.
- BMJ, Vol. 315, Issue 7109
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
journal, July 2009
- Liberati, A.; Altman, D. G.; Tetzlaff, J.
- BMJ, Vol. 339, Issue jul21 1
Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension
journal, January 1998
- Liu, Lisheng; Wang, Ji Guang; Gong, Lansheng
- Journal of Hypertension, Vol. 16, Issue 12
Systolic Blood Pressure Trajectory, Frailty, and All-Cause Mortality >80 Years of Age: Cohort Study Using Electronic Health Records
journal, June 2017
- Ravindrarajah, Rathi; Hazra, Nisha C.; Hamada, Shota
- Circulation, Vol. 135, Issue 24
Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association
journal, March 2017
- Benjamin, Emelia J.; Blaha, Michael J.; Chiuve, Stephanie E.
- Circulation, Vol. 135, Issue 10
Dementia and Disability Outcomes in Large Hypertension Trials: Lessons Learned from the Systolic Hypertension in the Elderly Program (SHEP) Trial
journal, January 2001
- Di Bari, Mauro; Pahor, Marco; Franse, Lonneke V.
- American Journal of Epidemiology, Vol. 153, Issue 1
Impact of amlodipine-based therapy among older and younger patients in the Anglo-Scandinavian Cardiac Outcomes Trial−Blood Pressure Lowering Arm (ASCOT-BPLA)
journal, January 2011
- Collier, David J.; Poulter, Neil R.; Dahlöf, Björn
- Journal of Hypertension, Vol. 29, Issue 3
Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension)
journal, November 1991
- Dahlöf, B.; Hansson, L.; Lindholm, L. H.
- The Lancet, Vol. 338, Issue 8778
Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial
journal, August 2008
- Peters, Ruth; Beckett, Nigel; Forette, Francoise
- The Lancet Neurology, Vol. 7, Issue 8
Randomised trial of treatment of hypertension in elderly patients in primary care.
journal, November 1986
- Coope, J.; Warrender, T. S.
- BMJ, Vol. 293, Issue 6555
The predictive ability of blood pressure in elderly trial patients
journal, January 2012
- Carr, Matthew J.; Bao, Yanchun; Pan, Jianxin
- Journal of Hypertension, Vol. 30, Issue 9
Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial
journal, October 1998
- Forette, Françoise; Seux, Marie-Laure; Staessen, Jan A.
- The Lancet, Vol. 352, Issue 9137
Principal Results of the Japanese Trial to Assess Optimal Systolic Blood Pressure in Elderly Hypertensive Patients (JATOS)
journal, January 2008
- JATOS Study Group,
- Hypertension Research, Vol. 31, Issue 12
Prevention of Heart Failure by Antihypertensive Drug Treatment in Older Persons With Isolated Systolic Hypertension
journal, July 1997
- Kostis, John B.
- JAMA: The Journal of the American Medical Association, Vol. 278, Issue 3
Trim and Fill: A Simple Funnel-Plot-Based Method of Testing and Adjusting for Publication Bias in Meta-Analysis
journal, June 2000
- Duval, Sue; Tweedie, Richard
- Biometrics, Vol. 56, Issue 2
Effects of individual risk factors on the residual risk of cardiovascular events in a population of treated Chinese patients with hypertension: data from the Felodipine Event Reduction (FEVER) study
journal, January 2010
- Zhang, Yuquing; Zhang, Xuezhong; Liu, Lisheng
- Journal of Hypertension, Vol. 28, Issue 10
The effect of antihypertensive treatment on the incidence of stroke and cognitive decline in the elderly: a meta-analysis
journal, March 2016
- Parsons, Christine; Murad, Mohammad Hassan; Andersen, Stuart
- Future Cardiology, Vol. 12, Issue 2
Benefits and Harms of Intensive Blood Pressure Treatment in Adults Aged 60 Years or Older: A Systematic Review and Meta-analysis
journal, January 2017
- Weiss, Jessica; Freeman, Michele; Low, Allison
- Annals of Internal Medicine, Vol. 166, Issue 6
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults
journal, May 2018
- Whelton, Paul K.; Carey, Robert M.; Aronow, Wilbert S.
- Journal of the American College of Cardiology, Vol. 71, Issue 19
Morbidity and mortality in the Systolic Hypertension in the Elderly Program (SHEP) pilot study.
journal, January 1989
- Perry, H. M.; Smith, W. M.; McDonald, R. H.
- Stroke, Vol. 20, Issue 1
Predominance of Isolated Systolic Hypertension Among Middle-Aged and Elderly US Hypertensives: Analysis Based on National Health and Nutrition Examination Survey (NHANES) III
journal, March 2001
- Franklin, Stanley S.; Jacobs, Milagros J.; Wong, Nathan D.
- Hypertension, Vol. 37, Issue 3
The Prevention of Dementia With Antihypertensive TreatmentNew Evidence From the Systolic Hypertension in Europe (Syst-Eur) Study
journal, October 2002
- Forette, Françoise
- Archives of Internal Medicine, Vol. 162, Issue 18
The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial
journal, January 2003
- Lithell, Hans; Hansson, Lennart; Skoog, Ingmar
- Journal of Hypertension, Vol. 21, Issue 5
Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years: A Randomized Clinical Trial
journal, June 2016
- Williamson, Jeff D.; Supiano, Mark A.; Applegate, William B.
- JAMA, Vol. 315, Issue 24
Shanghai trial of nifedipine in the elderly
journal, January 1996
- Gong, Lansheng; Zhang, Weizhong; Zhu, Yijun
- Journal of Hypertension, Vol. 14, Issue 10
Chinese Trial on Isolated Systolic Hypertension in the Elderly
journal, January 2000
- Wang, Ji-Guang
- Archives of Internal Medicine, Vol. 160, Issue 2
Target Blood Pressure for Treatment of Isolated Systolic Hypertension in the Elderly: Valsartan in Elderly Isolated Systolic Hypertension Study
journal, August 2010
- Ogihara, Toshio; Saruta, Takao; Rakugi, Hiromi
- Hypertension, Vol. 56, Issue 2
Outcomes of Intensive Blood Pressure Lowering in Older Hypertensive Patients
journal, February 2017
- Bavishi, Chirag; Bangalore, Sripal; Messerli, Franz H.
- Journal of the American College of Cardiology, Vol. 69, Issue 5
Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension
journal, September 1997
- Staessen, Jan A.; Fagard, Robert; Thijs, Lutgarde
- The Lancet, Vol. 350, Issue 9080
Clinical Practice Guidelines for the Management of Hypertension in the Community A Statement by the American Society of Hypertension and the International Society of Hypertension
journal, January 2014
- Weber, Michael A.; Schiffrin, Ernesto L.; White, William B.
- Journal of Hypertension, Vol. 32, Issue 1
2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults: Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8)
journal, February 2014
- James, Paul A.; Oparil, Suzanne; Carter, Barry L.
- JAMA, Vol. 311, Issue 5
No evidence that frailty modifies the positive impact of antihypertensive treatment in very elderly people: an investigation of the impact of frailty upon treatment effect in the HYpertension in the Very Elderly Trial (HYVET) study, a double-blind, placebo-controlled study of antihypertensives in people with hypertension aged 80 and over
journal, April 2015
- Warwick, Jane; Falaschetti, Emanuela; Rockwood, Kenneth
- BMC Medicine, Vol. 13, Issue 1
Results of the pilot study for the Hypertension in the Very Elderly Trial
journal, January 2003
- Bulpitt, Christopher J.; Beckett, Nigel S.; Cooke, Jonathan
- Journal of Hypertension, Vol. 21, Issue 12
Effects of Intensive Antihypertensive Treatment on Chinese Hypertensive Patients Older Than 70 Years
journal, April 2013
- Wei, Yong; Jin, Zhimin; Shen, Guoying
- The Journal of Clinical Hypertension, Vol. 15, Issue 6
Mortality and Morbidity Results from the European Working Party on high Blood Pressure in the Elderly Trial*1, *2
journal, June 1985
- Amery, A.
- The Lancet, Vol. 325, Issue 8442
Is a systolic blood pressure target <140 mmHg indicated in all hypertensives? Subgroup analyses of findings from the randomized FEVER trial
journal, February 2011
- Zhang, Y.; Zhang, X.; Liu, L.
- European Heart Journal, Vol. 32, Issue 12
The Study on COgnition and Prognosis in the Elderly (SCOPE) – Major CV events and stroke in subgroups of patients
journal, March 2005
- Trenkwalder, Peter; Elmfeldt, Dag; Hofman, Albert
- Blood Pressure, Vol. 14, Issue 1
Treatment of Hypertension in Patients 80 Years of Age or Older
journal, May 2008
- Beckett, Nigel S.; Peters, Ruth; Fletcher, Astrid E.
- New England Journal of Medicine, Vol. 358, Issue 18
A basic introduction to fixed-effect and random-effects models for meta-analysis
journal, April 2010
- Borenstein, Michael; Hedges, Larry V.; Higgins, Julian P. T.
- Research Synthesis Methods, Vol. 1, Issue 2